BIO Comments on SEC Proposal to Amend the Accelerated Filer and Large Accelerated Filer Definitions
November 11, 2019
In a recent letter, BIO applauded the Securities and Exchange Commission (SEC) for taking a proactive approach in amending its accelerated and large accelerated filer definitions.
“If adopted as proposed, these amendments will benefit startups and their investors by freeing up more capital to invest in hiring scientists and pursuing research and development. Our members strive to protect investors by keeping them informed, but the overwhelming success of the JOBS Act shows that there is little investor sentiment for a costly one-size-fits-all compliance requirement, and they are instead more concerned with our ability to attract talent and innovate.”
Download Full Comments Below
BIO Comments on SEC Accelerated Filer Proposed Rule
The Biotechnology Innovation Organization (BIO), BIO members and State affiliates urge immediate legislative action to repeal the harmful R&D amortization provision that went into effect earlier this year. The 2017 Tax Cuts and Jobs Act (TCJA)…
We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated…
In a recent letter, BIO applauded the Securities and Exchange Commission (SEC) for taking a proactive approach in amending its accelerated and large accelerated filer definitions.
“If adopted as proposed, these amendments will benefit startups and their investors by freeing up more capital to invest in hiring scientists and pursuing research and development. Our members strive to protect investors by keeping them informed, but the overwhelming success of the JOBS Act shows that there is little investor sentiment for a costly one-size-fits-all compliance requirement, and they are instead more concerned with our ability to attract talent and innovate.”